Evidence map›Paper›PMID 28750660›Full record

ArticleGenome biology2017

ReMixT: clone-specific genomic structure estimation in cancer.

Andrew W McPherson, Andrew Roth, Gavin Ha, Cedric Chauve, Adi Steif, Camila P E de Souza, Peter Eirew, Alexandre Bouchard-Côté, Sam Aparicio, S Cenk Sahinalp and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Genome biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Parsimonious Clone Tree Integration in cancer.Algorithms for molecular biology : AMB · 2022
    Article
  15. Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer.Reproductive biology and endocrinology : RB&E · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Andrew W McPhersonDepartment of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada.ORCID 0000-0002-5654-5101
Andrew RothDepartment of Statistics, Oxford University, 24-29 St Giles, Oxford, United Kingdom.
Gavin HaDana-Farber Cancer Institute, 450 Brookline Ave, Oxford, Boston, USA.
Cedric ChauveDepartment of Mathematics, Simon Fraser University, 8888 University Drive, Burnaby, BC, Canada.
Adi SteifDepartment of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada.
Camila P E de SouzaDepartment of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada.
Peter EirewDepartment of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada.
Alexandre Bouchard-CôtéDepartment of Statistics, University of British Columbia, 2329 West Mall, Vancouver, BC, Canada.
Sam AparicioDepartment of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada.
S Cenk SahinalpVancouver Prostate Centre, 2660 Oak Street, Vancouver, Canada.
Sohrab P ShahDepartment of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada. sshah@bccrc.ca.
BC Cancer Agency · CABroad Institute · USIndiana University Bloomington · USSimon Fraser University · CAUniversity of British Columbia · CAUniversity of Oxford · GB

Funding

Compressive genomics for large omics data sets: Algorithms applications & toolsR01GM108348 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BERGER, BONNIE · 2013 to 2019
$2.1M
CIHR FDN-143246CIHR MOP-115170NIGMS NIH HHS R01 GM108348
6 · The paper itself

Abstract

Somatic evolution of malignant cells produces tumors composed of multiple clonal populations, distinguished in part by rearrangements and copy number changes affecting chromosomal segments. Whole genome sequencing mixes the signals of sampled populations, diluting the signals of clone-specific aberrations, and complicating estimation of clone-specific genotypes. We introduce ReMixT, a method to unmix tumor and contaminating normal signals and jointly predict mixture proportions, clone-specific segment copy number, and clone specificity of breakpoints. ReMixT is free, open-source software and is available at http://bitbucket.org/dranew/remixt .

Indexed as

Genome, HumanModels, StatisticalSoftwareAlgorithmsAnimalsBreast NeoplasmsCell CountClone CellsCystadenocarcinoma, SerousDNA Copy Number VariationsFemaleGenotypeHeterograftsHumansInternetMiceCancer genomicsCopy number variationDNA sequencingGenomic rearrangementTumour heterogeneity

Identifiers

PMID28750660
PMCPMC5530528
OpenAlexW2741106212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.